Jennison Associates’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-11,588
| Closed | -$277K | – | 740 |
|
|
2019
Q4 | $277K | Buy |
+11,588
| New | +$277K | ﹤0.01% | 611 |
|
|
2016
Q1 | – | Sell |
-858,523
| Closed | -$44.2M | – | 671 |
|
|
2015
Q4 | $44.2M | Buy |
858,523
+203,505
| +31% | +$10.5M | 0.04% | 304 |
|
|
2015
Q3 | $27.9M | Buy |
655,018
+5,118
| +0.8% | +$218K | 0.03% | 390 |
|
|
2015
Q2 | $29.6M | Buy |
649,900
+6,543
| +1% | +$298K | 0.03% | 411 |
|
|
2015
Q1 | $24.4M | Buy |
643,357
+2,058
| +0.3% | +$78.1K | 0.02% | 424 |
|
|
2014
Q4 | $18.2M | Sell |
641,299
-706
| -0.1% | -$20K | 0.02% | 445 |
|
|
2014
Q3 | $16.2M | Buy |
642,005
+959
| +0.1% | +$24.2K | 0.02% | 449 |
|
|
2014
Q2 | $18.7M | Sell |
641,046
-76,170
| -11% | -$2.22M | 0.02% | 430 |
|
|
2014
Q1 | $18.6M | Sell |
717,216
-353,864
| -33% | -$9.17M | 0.02% | 444 |
|
|
2013
Q4 | $27.6M | Sell |
1,071,080
-7,714
| -0.7% | -$199K | 0.03% | 410 |
|
|
2013
Q3 | $28.9M | Sell |
1,078,794
-6,980
| -0.6% | -$187K | 0.03% | 393 |
|
|
2013
Q2 | $26.7M | Buy |
+1,085,774
| New | +$26.7M | 0.03% | 390 |
|